ADC Therapeutics (ADCT) Return on Assets (2021 - 2026)
ADC Therapeutics (ADCT) posted Return on Assets of 0.0% for Q1 2026, up 4.41% sequentially from 0.0% in Q4 2025, and little changed YoY from 0.0% in Q1 2025.
ADC Therapeutics (ADCT) Return on Assets (2021 - 2026) Analysis & Trends
ADC Therapeutics has reported Return on Assets for 6 years, with the latest figure at 0.0% in Q1 2026.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2022 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Assets improved to 0.0% in Q1 2026 per ADCT's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q4 2022 and troughed at 0.0% in Q2 2025.
- A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
- The widest YoY moves for Return on Assets: up 0 bps in 2022, down 0 bps in 2022.
- Over 5 years, Return on Assets stood at 0.0% in 2022, then slipped by 27 bps to 0.0% in 2023, then slipped by 1 bps to 0.0% in 2024, then slipped by 19 bps to 0.0% in 2025, then rose by 4 bps to 0.0% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 0.00% |
| 10 | ADC Therapeutics | 152.41 Mn | -66.70 Mn | 17.14 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |